Although the serum CEA levels considered to be a good predictor for recurrent disease, Moertel et al., reported that CEA testing was most sensitive for hepatic or retroperitoneal metastasis and relatively insensitive for local, pulmonary, or peritoneal involvement [13]. The gene discussed is CEACAM5; the disease is metastasis.